Amicus Therapeutics, Inc. (0HF9.L) LSE
17.09
+2.63(+18.19%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
17.09
+2.63(+18.19%)
Currency In USD
| Market Cap | 4.39B |
| Enterprise Value | 4.66B |
| P/E Ratio | -165.17 |
| PEG Ratio | 1.7 |
| Price/Sales Ratio | 7.17 |
| Price/Book Ratio | 16.33 |
| Enterprise/Revenue | 7.6 |
| Enterprise/EBITDA | 89.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.04 |
| Operating Margin | 0.05 |
| Return On Assets | -0.03 |
| Return On Equity | -0.12 |
| Revenue | 634.21M |
| Revenue/Share | 2.05 |
| Gross Profit | 553.82M |
| EBITDA | 41.95M |
| Net Income | -27.11M |
| Diluted EPS | -0.09 |
| Total Cash | 293.54M |
| Total Cash/Share | 0.95 |
| Total Debt | 483.33M |
| Total Debt/Equity | 1.76 |
| Current Ratio | 2.84 |
| Book Value Per Share | 0.89 |
| 52-Week Change | 174.76 |
| 52-Week High | 17.09 |
| 52-Week Low | 9.74 |
| Moving Average 50 Days | 13.1 |
| Moving Average 200 Days | 12.19 |
| Average Volume | 814 |
| Shares Outstanding | 308.32M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |